TY - JOUR
T1 - Impact of a transition-of-care pharmacist during hospital discharge
AU - Balling, Lauren
AU - Erstad, Brian L.
AU - Weibel, Kurt
PY - 2015/7/1
Y1 - 2015/7/1
N2 - Objective: To assess the impact of a transition-of-care pharmacist during hospital discharge. Setting: An academic medical center in southern Arizona. Practice description: One pharmacist coordinated patient discharges in two inpatient units from August 2012 through July 2013. The pharmacist attended interdisciplinary discharge coordination meetings, ensured appropriate discharge orders, facilitated the filling of medications, and educated patients on discharge medications. Practice innovation: The implementation of a transition-of-care pharmacist to provide discharge medication reconciliation and education. Main outcome measures: Readmission rates and medication interventions made by the pharmacist at discharge. Results: The pharmacist was involved in the education of 1,011 patients and performed 452 interventions. There were more readmissions per month in the control year versus the year of pharmacist involvement (median 27.5 vs. 25, P = 0.0369). Interventions made by the pharmacist to improve discharge management included starting an omitted medication (23.5%), preventing multiple discharge problems (16.4%), avoiding duplication of therapy (15.7%), correcting insurance issues related to medication coverage (12.2%), changing an improper medication dose or quantity (11.3%), changing an inappropriate prescription for a medication (5.1%), preventing a drug interaction (3.3%), and resolving other problems (12.6%). The most common medication classes involved were antimicrobial agents (9.1%), anticoagulants (8%), antihyperglycemic agents (3.8%), other drug classes (24%), and multiple drug classes (35%). Conclusion: A transition-of-care pharmacist is in a unique position to educate patients on hospital discharge, to intercept a substantial number of medication errors, and to resolve insurance issues that may lead to adherence problems. These improvements in care may result in reduced hospital readmission rates.
AB - Objective: To assess the impact of a transition-of-care pharmacist during hospital discharge. Setting: An academic medical center in southern Arizona. Practice description: One pharmacist coordinated patient discharges in two inpatient units from August 2012 through July 2013. The pharmacist attended interdisciplinary discharge coordination meetings, ensured appropriate discharge orders, facilitated the filling of medications, and educated patients on discharge medications. Practice innovation: The implementation of a transition-of-care pharmacist to provide discharge medication reconciliation and education. Main outcome measures: Readmission rates and medication interventions made by the pharmacist at discharge. Results: The pharmacist was involved in the education of 1,011 patients and performed 452 interventions. There were more readmissions per month in the control year versus the year of pharmacist involvement (median 27.5 vs. 25, P = 0.0369). Interventions made by the pharmacist to improve discharge management included starting an omitted medication (23.5%), preventing multiple discharge problems (16.4%), avoiding duplication of therapy (15.7%), correcting insurance issues related to medication coverage (12.2%), changing an improper medication dose or quantity (11.3%), changing an inappropriate prescription for a medication (5.1%), preventing a drug interaction (3.3%), and resolving other problems (12.6%). The most common medication classes involved were antimicrobial agents (9.1%), anticoagulants (8%), antihyperglycemic agents (3.8%), other drug classes (24%), and multiple drug classes (35%). Conclusion: A transition-of-care pharmacist is in a unique position to educate patients on hospital discharge, to intercept a substantial number of medication errors, and to resolve insurance issues that may lead to adherence problems. These improvements in care may result in reduced hospital readmission rates.
UR - http://www.scopus.com/inward/record.url?scp=84936940409&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84936940409&partnerID=8YFLogxK
U2 - 10.1331/JAPhA.2015.14087
DO - 10.1331/JAPhA.2015.14087
M3 - Article
C2 - 26161488
AN - SCOPUS:84936940409
SN - 1544-3191
VL - 55
SP - 443
EP - 448
JO - Journal of the American Pharmacists Association
JF - Journal of the American Pharmacists Association
IS - 4
ER -